These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 9694744
1. Multiple factors in the transformation of essential thrombocythemia to acute leukemia or myelodysplastic syndrome. Liu TC, Suri R. Blood; 1998 Aug 15; 92(4):1465-6. PubMed ID: 9694744 [No Abstract] [Full Text] [Related]
2. Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and acute myeloid leukemia. Suleiman Y, Dalia S, Liu JJ, Bowers JW, Padron E, Lancet JE, Fulp W, Moscinski LC, Komrokji RS, Zuckerman KS, Zhang L. Leuk Res; 2016 Mar 15; 42():52-8. PubMed ID: 26894965 [Abstract] [Full Text] [Related]
3. Myelodysplasia progressing to acute myeloid leukemia in monozygotic twins with monosomy 7 as sole abnormality. Udayakumar AM, Surekhatony M, Wali YA. Leuk Lymphoma; 2014 Nov 15; 55(11):2672-4. PubMed ID: 24598016 [No Abstract] [Full Text] [Related]
4. Hidden chromosomal aberrations are rare in primary myelodysplastic syndromes with evolution to acute myeloid leukaemia and normal cytogenetics. Trost D, Hildebrandt B, Müller N, Germing U, Royer-Pokora B. Leuk Res; 2004 Feb 15; 28(2):171-7. PubMed ID: 14654082 [Abstract] [Full Text] [Related]
5. A mutation in PTPN11 may drive leukemic transformation in a case of essential thrombocythemia. Guo BB, Liang J, Allcock RJN, Mirzai B, Augustson B, Howman R, Fuller KA, Erber WN. Leuk Lymphoma; 2018 Jan 15; 59(1):245-248. PubMed ID: 28587547 [No Abstract] [Full Text] [Related]
6. Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia. Lezon-Geyda K, Najfeld V, Johnson EM. Leukemia; 2001 Jun 15; 15(6):954-62. PubMed ID: 11417483 [Abstract] [Full Text] [Related]
8. [A case of myelodysplastic syndrome with abnormal chromosome t (3;4), proliferation of megakaryocytes and myelofibrosis, transition to overt leukemia]. Nehashi Y, Iwabuchi H, Tsuda A, Kawanishi Y, Tauchi T, Kawaguchi M, Oyashiki K, Sotoyama K. Nihon Naika Gakkai Zasshi; 1991 May 10; 80(5):759-60. PubMed ID: 1875112 [No Abstract] [Full Text] [Related]
9. Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells. Engel H, Drach J, Keyhani A, Jiang S, Van NT, Kimmel M, Sanchez-Williams G, Goodacre A, Andreeff M. Leukemia; 1999 Apr 10; 13(4):568-77. PubMed ID: 10214863 [Abstract] [Full Text] [Related]
10. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients. Rossi G, Pelizzari AM, Bellotti D, Tonelli M, Barlati S. Leukemia; 2000 Apr 10; 14(4):636-41. PubMed ID: 10764149 [Abstract] [Full Text] [Related]